Prosecution Insights
Last updated: August 16, 2026

Osaka University

54 pending office actions • 38 art units • 54 examiners • 0 of 54 (0%) have an AI response strategy ready • 46 patents granted in the last 365 days

Portfolio Summary

54
Total Pending OAs
33
Non-Final OAs
18
Final Rejections
3
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 22 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

7
Overdue
3
Due this week
7
Due this month
4
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 22 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (7)Due ≤ 7 days (3)Due ≤ 30 days (7)Due ≤ 60 days (4)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

32
Hard (59%)
20
Medium (37%)
1
Easy (2%)
1
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only2 (4%)
§101 + other4 (7%)
§103 only12 (22%)
§102 only3 (6%)
§112 only1 (2%)
Double-patenting + other5 (9%)
Multi-statute (no §101)26 (48%)
No statute on record1 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

30
Life Sciences
56% of docket
1
Information Tech
2% of docket
1
Communications
2% of docket
4
Semiconductors
7% of docket
8
Mechanical / Eng
15% of docket
10
Business / Other
19% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

540 h
Manual time on pending OAs
108 h
Time saved (low, 20%)
189 h
Time saved (mid, 35%)
4.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
PHAM, KATHERINE-PH MINH 1 56.5% +53.6%
NGUYEN, NGOC-ANH THI 1 30.0% +48.4%
RUIZ, JOSHUA DAMIAN 1 0.0% +0.0%
SHTERENGARTS, SAMANTHA L 1 79.3% +8.0%
STONER, KILEY SHAWN 1 80.8% +15.4%
BEHARRY, ZANNA MARIA 1 23.2% +52.7%
KIM, RICHARD H 1 81.8% +5.1%
CHORBAJI, MONZER R 1 76.4% +21.2%
FITZGERALD, JOHN P 1 75.1% +2.2%
CONLON, MARISA V 1 41.0% +39.0%

Hard Cases (33)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17289544 THERAPEUTIC AGENT FOR ARTHRITIS GIBBS, TERRA C 50d overdue
18042430 GRAPHENE GRID, METHOD FOR PRODUCING GRAPHENE GRID, AND METHOD FOR ANALYZING STRUCTURAL ANALYSIS TARGET SUBSTANCE STOFFA, WYATT A 44d overdue
17631072 COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF MESENCHYMAL STEM CELLS REYNOLDS, FRED H 44d overdue
17641669 CATHETER FOR AORTIC VALVULOPLASTY DUBOSE, LAUREN 35d overdue
17639483 PARACENTESIS ASSISTANCE SYSTEM, PARACENTESIS ASSISTANCE METHOD, AND PROGRAM GUERRERO ROSARIO, ANA VERUSKA 6d
17271902 METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS SMALL, KATHERINE R 6d
18032169 JOINT EVALUATION APPARATUS, METHOD, AND STORAGE MEDIUM ROBERTS, ANNA L 14d
18016978 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR DIABETES VAN BUREN, LAUREN K 19d

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18883477 DRUG AND PRODUCTION METHOD THEREFOR NGUYEN, NGOC-ANH THI 14d
18710932 IRRADIATION DEVICE AND IRRADIATION METHOD CONLON, MARISA V 62d
18849637 WOUND TREATMENT DEVICE AND WOUND COVERING USED THEREIN PHAM, KATHERINE-PH MINH
18684475 TAILORED BLANK MATERIAL, METHOD FOR MANUFACTURING SAME, AND PRESS-MOLDED ARTICLE STONER, KILEY SHAWN
18836137 METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO RETINAL PIGMENT EPITHELIAL CELLS BEHARRY, ZANNA MARIA
18723938 STERILIZATION METHOD AND STERILIZATION DEVICE CHORBAJI, MONZER R

Top Art Units

Art UnitApps
1759 3
1632 3
1615 2
1658 2
3684 1
3725 1
2855 1
3643 1
2667 1
1787 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18849637 WOUND TREATMENT DEVICE AND WOUND COVERING USED THEREIN PHAM, KATHERINE-PH MINH §103§112 Non-Final OA Pending Sep 23, 2024
18883477 DRUG AND PRODUCTION METHOD THEREFOR NGUYEN, NGOC-ANH THI 1615 §103 Non-Final OA 14d Pending Sep 12, 2024
18844708 TREATMENT-METHOD SELECTION ASSISTANCE APPARATUS, TREATMENT-METHOD SELECTION ASSISTANCE METHOD, AND COMPUTER-READABLE MEDIUM RUIZ, JOSHUA DAMIAN 3684 §101§103§112 Final Rejection 33d Pending Sep 06, 2024
18841742 PHARMACEUTICAL COMPOSITION FOR PREVENTING AND/OR TREATING RENAL DISEASE SHTERENGARTS, SAMANTHA L §102§112DP Non-Final OA Pending Aug 27, 2024
18684475 TAILORED BLANK MATERIAL, METHOD FOR MANUFACTURING SAME, AND PRESS-MOLDED ARTICLE STONER, KILEY SHAWN 3725 §102§103§112 Non-Final OA Pending Aug 09, 2024
18836137 METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO RETINAL PIGMENT EPITHELIAL CELLS BEHARRY, ZANNA MARIA §102§103DP Non-Final OA Pending Aug 06, 2024
18795401 LIQUID CRYSTAL OPTICAL ELEMENT AND DISPLAY DEVICE KIM, RICHARD H §103§112 Non-Final OA Pending Aug 06, 2024
18723938 STERILIZATION METHOD AND STERILIZATION DEVICE CHORBAJI, MONZER R §102 Non-Final OA Pending Jun 25, 2024
18716786 A STRAIN MEASUREMENT DEVICE AND A STRAIN MEASUREMENT METHOD FITZGERALD, JOHN P 2855 §102§103 Non-Final OA Pending Jun 05, 2024
18710932 IRRADIATION DEVICE AND IRRADIATION METHOD CONLON, MARISA V 3643 §102§103§112 Final Rejection 62d Pending May 16, 2024
18662314 POROUS PARTICLES SINGH-PANDEY, ARTI R 1759 §102§112 Non-Final OA 33d Pending May 13, 2024
18696454 WALL THICKNESS ESTIMATION METHOD, RECORDING MEDIUM, TRAINING METHOD, MODEL CONSTRUCTION METHOD, WALL THICKNESS ESTIMATION DEVICE, AND WALL THICKNESS ESTIMATION SYSTEM SHIN, SOO JUNG 2667 §103DP Final Rejection 8d overdue Pending Mar 28, 2024
18687110 LAMINATED BODY HAVING RESIN LAYER AND METAL LAYER AND PRODUCTION METHOD FOR SAME JACKSON, MONIQUE R 1787 §103 Final Rejection Pending Feb 27, 2024
18684207 DNP-NMR POLARIZING AGENT, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME MOSHER, ERIC PARKER §102§103§112 Non-Final OA Pending Feb 16, 2024
18684478 METHOD FOR FRICTION-JOINING GALVANIZED STEEL SHEETS, AND JOINED STRUCTURE SAAD, ERIN BARRY 1735 §103 Non-Final OA Pending Feb 16, 2024
18293488 RADIOLABELED COMPOUND AND USE THEREOF LEWOCZKO, EVAN MICHAEL §103§112DP Non-Final OA Pending Jan 30, 2024
18577263 Mature-Hepatocyte Transdifferentiation Suppressing Composition MOTEVALLI, OROD 1628 §103 Non-Final OA Pending Jan 22, 2024
18580106 RARE-EARTH-DOPED SEMICONDUCTOR DEVICE AND METHOD FOR PRODUCING THE SAME WIEGAND, TYLER J 2812 §102§103 Non-Final OA Pending Jan 17, 2024
18579988 Method for Creating Isotope Distribution Data SIMMONS, VALERIE MICHELLE §101§102§103 Non-Final OA Pending Jan 17, 2024
18392869 CHIMERIC DOUBLE-STRANDED NUCLEIC ACID ZARA, JANE J §112DP Non-Final OA Pending Dec 21, 2023
18390090 COMPOSITE SOLID ELECTROLYTE AND SOLID-STATE BATTERY GODO, OLATUNJI A §103 Non-Final OA Pending Dec 20, 2023
18560067 POLYMERIC COMPOUND OF GLUCURONIC ACID WITH PHENOLIC GROUPS, GEL-FORMING COMPOSITION COMPRISING SUCH A COMPOUND AND METHOD FOR PRODUCING THE SAME ALLEY, GENEVIEVE S 1617 §102§112 Non-Final OA Pending Nov 09, 2023
18282450 PERICYTE HAVING BASIC FIBROBLAST GROWTH FACTOR (BFGF) GENE INTRODUCED THEREIN TICHY, JENNIFER M.H. 1653 §102§103 Non-Final OA Pending Sep 15, 2023
18279557 CELL FUSION METHOD BELYAVSKYI, MICHAIL A 1644 §102 Non-Final OA Pending Aug 30, 2023
18278931 TEST FOR MILD COGNITIVE IMPAIRMENT MCCOLLUM, ANDREA K 1674 §101§102§112 Final Rejection Pending Aug 25, 2023
18275245 SPECTROMETRY DEVICE AND SPECTROMETRY METHOD SCHNASE, PAUL DANIEL 2877 §103 Final Rejection 5d Pending Aug 01, 2023
18142863 COPOLYMER BLAND, ALICIA 1759 §102 Non-Final OA Pending May 03, 2023
18032169 JOINT EVALUATION APPARATUS, METHOD, AND STORAGE MEDIUM ROBERTS, ANNA L 3791 §101 Final Rejection 14d Pending Apr 15, 2023
18126045 TEMPERATURE ESTIMATION DEVICE, AIR CONDITIONING CONTROL DEVICE, AND AIR CONDITIONING SYSTEM CHANG, VINCENT WEN-LIANG 2119 §103 Non-Final OA 59d overdue Pending Mar 24, 2023
18025300 MEDICAMENT FOR TREATING CANCER, IMMUNOSTIMULANT, AND METHOD FOR SCREENING FOR ANTI-CANCER SUBSTANCE AUDET, MAURY A 1654 §102§103 Final Rejection Pending Mar 08, 2023
18043507 METHOD OF PRODUCING THREE-DIMENSIONAL TISSUE BODY AND THREE-DIMENSIONAL TISSUE BODY REGLAS, GILLIAN CHELSEA 1632 §101§102§103§112Other Non-Final OA 40d Pending Feb 28, 2023
18023573 IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN WEIDNER, ADAM M 1600 §103 Non-Final OA Pending Feb 27, 2023
18042430 GRAPHENE GRID, METHOD FOR PRODUCING GRAPHENE GRID, AND METHOD FOR ANALYZING STRUCTURAL ANALYSIS TARGET SUBSTANCE STOFFA, WYATT A 2881 §103§112 Non-Final OA 44d overdue Pending Feb 21, 2023
18157250 METHOD OF ASSISTING DIAGNOSIS OF INFLAMMATORY BOWEL DISEASE COUNTS, GARY W 1678 §112 Non-Final OA Pending Jan 20, 2023
18016978 PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR DIABETES VAN BUREN, LAUREN K 1638 §103§112Other Non-Final OA 19d Pending Jan 19, 2023
18008652 MULTI-COMPONENT SYSTEM ALLOY ROE, JESSEE RANDALL 1759 §103 Final Rejection 14d Pending Dec 06, 2022
17999347 EPITHELIAL CANCER THERAPEUTIC AGENT WORSHAM, JESSICA N 1615 §102§103 Non-Final OA Pending Nov 18, 2022
17925099 GOLD NANOPARTICLE-CONTAINING MEDICINE GREENE, IVAN A 1619 §102§103§112 Non-Final OA Pending Nov 14, 2022
17925123 TUBE ASSEMBLY FOR LIVING ORGANISM AND MEASUREMENT APPARATUS FOR LIVING ORGANISM CHOU, WILLIAM B 3795 §103 Final Rejection 15d Pending Nov 14, 2022
17925225 CUG REPEAT SEQUENCE BINDING AGENT VANHORN, ABIGAIL LOUISE 1636 §102§103§112 Non-Final OA Pending Nov 14, 2022
17910588 SOLID-PHASE SPOT-WELDING METHOD AND SOLID-PHASE SPOT-WELDING DEVICE FERDOUSI, FAHMIDA NMN 3761 §103§112 Non-Final OA Pending Sep 09, 2022
17910629 SPHEROID FORMATION PROMOTER XU, QING 1656 §102§103§112 Non-Final OA Pending Sep 09, 2022
17802045 RESIN MATERIAL INCLUDING SILOXANE-BOND-CONTAINING POLYMER HAVING HOST GROUP AND/OR GUEST GROUP BERRO, ADAM JOSEPH 1765 §102§103 Final Rejection Pending Aug 24, 2022
17801115 DIGESTIVE FLUID LEAK PREVENTATIVE MATERIAL AND ORGAN PROTECTIVE MATERIAL AGAINST DIGESTION BY DIGESTIVE FLUID KATAKAM, SUDHAKAR 1658 §103 Non-Final OA 19d Pending Aug 19, 2022
17775780 ENHANCER POLYNUCLEOTIDE RESPONDING TO HEART FAILURE AND EXPRESSION VECTOR INCLUDING SAID ENHANCER POLYNUCLEOTIDE SINGH, ANOOP KUMAR 1632 §102§103§112 Final Rejection 27d Pending May 10, 2022
17631072 COMPOSITION FOR PROMOTING GROWTH OR SUPPRESSING DECREASE OF MESENCHYMAL STEM CELLS REYNOLDS, FRED H 1658 §103§112 Final Rejection 44d overdue Pending Apr 29, 2022
17769222 CONDUCTIVE FILM, DISPERSION, MANUFACTURING METHODS FOR THESE, AND DEVICE INCLUDING CONDUCTIVE FILM PATEL, RONAK C 1788 §103 Final Rejection Pending Apr 14, 2022
17641669 CATHETER FOR AORTIC VALVULOPLASTY DUBOSE, LAUREN 3771 §103§112 Final Rejection 35d overdue Pending Mar 09, 2022
17639483 PARACENTESIS ASSISTANCE SYSTEM, PARACENTESIS ASSISTANCE METHOD, AND PROGRAM GUERRERO ROSARIO, ANA VERUSKA 3794 §103§112 Non-Final OA 6d Pending Mar 01, 2022
17441602 BRAIN BLOOD VESSEL MODEL AND DEVICE DHAR, MATASHA 1632 §102§103§112 Non-Final OA 50d Pending Sep 21, 2021
17289544 THERAPEUTIC AGENT FOR ARTHRITIS GIBBS, TERRA C 1635 §102§103§112 Final Rejection 50d overdue Pending Apr 28, 2021
17271902 METHOD FOR EVALUATING ANTI-INFECTIVE DRUGS, VACCINES, ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS SMALL, KATHERINE R 1633 §103§112 Final Rejection 6d Pending Feb 26, 2021
16971604 ANALYSIS/DIAGNOSIS METHOD UTILIZING RNA MODIFICATION ANGELL, JON E 1637 §101 Final Rejection Pending Nov 10, 2020
17085040 Pharmaceutical Composition for Cancer Treatment STOICA, ELLY GERALD 1647 Other Non-Final OA 9d overdue Pending Oct 30, 2020

Managing Osaka University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month